gene expression analysis
Scipher Medicine to Expand Arthritis Therapy Response Test, Aiming to Maximize Medicare Coverage
Premium
The company is collecting the data necessary to add at least two other drugs to its current TNFi response predictor, which it believes will accelerate adoption.
Mainz Biomed Stock Spikes on Positive Data for mRNA-Enhanced Colorectal Cancer Screening Assay
In top-line data, Mainz Biomed's enhanced ColoAlert detected CRC with 94 percent sensitivity and 97 percent specificity, and advanced adenoma with 81 percent sensitivity.
The Swedish bioinformatics firm is targeting February 2025 for regulatory approval of its Qlucore Diagnostics software for transcriptomics-based ALL testing.
AccuStem Sciences, EmeritusDx Partner to Further Develop Breast Cancer Recurrence Test
The firms will work together to validate the 20-gene StemPrintER assay as a tool for guiding breast cancer treatment.
CareDx Stock Rises Following American Society of Transplant Surgeons' Position Statement on Test Use
ASTS supports the use of dd-cfDNA as a biomarker of kidney transplant rejection, as well as peripheral blood gene expression profiling to help rule out heart transplant rejection.